Enhanced expression of integrin a v b 3 is commonly used as a biomarker for angiogenesis, which is one of the key pathophysiologic processes in cerebral infarct. Integrin a v b 3 can be imaged with arginine-glycine-aspartic acid (RGD) peptide agents. In this study, characteristics of positron emission tomography (PET) using a 68 Ga-labeled RGD were investigated in pediatric cerebral infarct.
Ga-RGD
PET has a potential for molecular imaging of integrin a v b 3 expression in cerebral infarct as a biomarker of angiogenesis.
I N ISCHEMIC CEREBRAL DISORDERS, angiogenesis is one of the key pathophysiologic processes for spontaneous recovery or therapeutic interventions. 1, 2 With recent progress in molecular imaging, it has been actively studied to assess angiogenesis directly and noninvasively by imaging methods. Molecular targets such as vascular endothelial growth factor (VEGF) and integrin a v b 3 have been focused as targets in the development of imaging probes. 3, 4 Integrin a v b 3 expression is enhanced on vascular endothelium with angiogenic activation and can be imaged with a tripeptide moiety of arginine-glycine-aspartic acid (RGD). 5, 6 We also developed an RGD agent labeled with 68 Ga ( 68 Ga-RGD) and successfully obtained positron emission tomography (PET) images for angiogenesis in a tumor model. 7 This agent was a conjugate of a cyclic RGD and 2-(p-isothiocyanoatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (SCN-Bn-NOTA) labeled with 68 Ga.
68
Ga-RGD was blocked by a cold RGD agent in an in vitro binding assay and an animal model, suggesting specific binding to the integrin a v b 3 .
7
In ischemic stroke, angiogenesis imaging with 64 Cu-DOTA-VEGF PET was tried in a rat model, visualizing enhanced angiogenesis after stroke. 8 RGD peptide imaging was successfully obtained in myocardial infarct and peripheral muscular ischemia in animal and human studies. 9, 10 However, there has been no report on RGD peptide imaging in cerebral infarct. Moyamoya disease (MMD), a spontaneous and progressive steno-occlusive change in the internal carotid arteries and their branches, is one of the most important causes of cerebral infarct in children. 11 In the current study, we acquired 68 Ga-RGD PET in pediatric MMD patients and investigated the characteristics of 68 Ga-RGD PET images in cerebral infarct. To our knowledge, this is the first human study that investigated angiogenesis imaging using RGD agents in cerebral infarct.
Methods
A prospective study, in which cerebral angiogenesis after revascularization surgery was assessed using 68 Ga-RGD PET, enrolled 26 pediatric patients with MMD. The study was approved by the Institutional Review Board of the Seoul National University Hospital. Among them, 10 patients (age 1-14 years, M:F 5 6:4) presented with 17 lesions of cerebral infarct before PET scans and were included in the current study. In the study protocol, 68 Ga-RGD was prepared as previously reported, 7 and brain PET images were acquired 20 minutes after 68 Ga-RGD injection (111 MBq). Brain magnetic resonance imaging (MRI) and 99m Tc-HMPAO perfusion single-photon emission computed tomography (SPECT) were also performed before PET scans. PET images were visually analyzed by two nuclear medicine physicians blinded to clinical information, and 68 Ga-RGD uptake was quantified for the volume of interest (VOI) drawn for each infarct lesion with the aid of slice-matched MRI. The uptake was expressed as a lesion to control ratio (LCR) by quantifying another VOI that was drawn for the cerebral parenchyme of noninfarcted contralateral hemisphere.
The LCR of infarct lesions was analyzed with regard to postinfarct time interval (PTI) between infarct onset and PET scanning to assess characteristics of angiogenesis imaging in cerebral infarct. Infarct onset was determined by the first presentation of clinical symptoms or first MRIbased confirmation of acute infarct when the onset of clinical symptom was vague. Infarct lesions for which the PTI was , 30 days were classified as recent infarct, and the others were classified as chronic infarct. Additionally, the LCR was analyzed with regard to perfusion state shown on SPECT images. In statistical analyses, the Student t-test and Mann-Whitney test were performed to compare groups. Proportions were compared using the Fisher exact test. Additionally, Pearson correlation coefficient was calculated for correlation analysis.
Results
The clinical characteristics of the patients included in the current study are summarized in Table 1 . Of the 17 infarct lesions, 13 lesions were diagnosed with cerebral infarct by presentation of neurologic symptoms and following MRI; Figure 1A ). A representative case in which recent and chronic infarct lesions existed together showed marked 68 Ga-RGD uptake only in a recent infarct lesion ( Figure 1 , B and C).
Ga-RGD PET and Perfusion State on SPECT
For 10 recent infarct lesions, perfusion SPECT was performed 2.9 6 3.2 (range 1-9) days before 68 Ga-RGD PET. Among them, three lesions showed postinfarct hyperperfusion and the other seven lesions showed a perfusion decrease of variable degree (see Table 1 ). The LCRs of the three lesions with hyperperfusion were significantly higher than those of the other lesions (9.93 6 4.95 and 3.03 6 3.00, respectively; p 5 .033). A representative case in which recent infarct lesions with or without hyperperfusion existed together showed more definite 68 Ga-RGD uptake in a lesion with hyperperfusion ( Figure 2 ).
Discussion
In this study, 68 Ga-RGD PET, targeting integrin a v b 3 expression, was investigated in pediatric cerebral infarct. Increased uptake of 68 Ga-RGD was observed in recent Ga-RGD PET (C) of a patient who had recent and chronic infarct lesions together, only the recent infarct (arrowhead, PTI 5 10 days, lesion number 3) showed definite 68 Ga-RGD uptake, whereas the chronic infarct did not (arrow, PTI 5 56 days, lesion number 5). High uptake in the cranium was observed in craniotomy sites for revascularization surgery (C).
infarct lesions with a significant correlation with postinfarct hyperperfusion, suggesting angiogenic activation in the acute postinfarct state.
After cerebral infarct, angiogenesis is known to be enhanced in the acute phase. On 64 Cu-DOTA-VEGF PET, uptake remained elevated until 16 days after infarct. 8 Integrin a v b 3 expression was also found upregulated in angiogenic endothelium after cerebral infarct, with a decrease after 7 days. 12, 13 Uptake of 68 Ga-RGD in the current study was consistent with these previous studies, demonstrating a peak in the acute stage and a decrease with time. Thus, 68 Ga-RGD PET is speculated to successfully visualize serial change of integrin a v b 3 expression in cerebral infarct. As integrin a v b 3 is expressed on activated macrophages 14 as well as angiogenic endothelium, the increased uptake would be a mixed result of inflammation and angiogenesis. However, uptake of 68 Ga-RGD had a significant correlation with postinfarct hyperperfusion in the current study. Post-ischemic hyperperfusion on 99m Tc-HMPAO SPECT is induced by an increase in cerebral blood volume and blood flow, 15 as well as new vessel formation. 16 Thus, increased uptake of 68 Ga-RGD is indicative of endothelial angiogenic activation accompanying postinfarct hyperperfusion, at least as part of the mechanism.
Angiogenesis in cerebral infarct is a biomarker for disease progress or functional prognosis, as well as a therapeutic target. 17, 18 Serum VEGF, which is related to angiogenesis, had a relationship with severity of stroke and was regarded as a prognostic factor predicting functional outcome. 19, 20 Angiogenesis imaging can provide a better understanding of angiogenic activation after infarct and can be applied to angiogenesis-targeting treatment for patient selection or efficacy monitoring.
68 Ga-RGD PET demonstrated the potential for angiogenesis imaging for such purposes.
In this study, only pediatric patients with MMD were selected, which may influence the imaging findings. Additionally, disruption of the blood-brain barrier (BBB) would have influenced the uptake of 68 Ga-RGD like many other tracer imaging methods. BBB disruption is also one of the mechanisms for postinfarct hyperperfusion. To specifically assess angiogenic activity using 68 Ga-RGD PET in infarct lesions, the influence of BBB disruption should be adjusted using other methods, such as BBB imaging. The influence of hyperperfusion also needs to be considered because hyperperfusion per se may induce increased uptake of imaging tracers. Further studies are warranted to investigate the clinical roles of 68 Ga-RGD PET in general infarct patients and specific estimation methods for angiogenic activity with adjustment of BBB disruption and hyperperfusion effect.
This study demonstrates the feasibility and characteristics of 68 Ga-RGD PET in human cerebral infarct as a molecular imaging method for integrin a v b 3 expression. 68 Ga-RGD PET would be effective for both diagnosis and treatment monitoring in ischemic stroke, particularly with novel therapies targeting angiogenesis or endothelial activation.
